Steward Partners Investment Advisory’s Cellectis CLLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-100
Closed -$1K 3196
2021
Q3
$1K Hold
100
﹤0.01% 3053
2021
Q2
$2K Hold
100
﹤0.01% 6855
2021
Q1
$2.02K Sell
100
-200
-67% -$4.95K ﹤0.01% 3224
2020
Q4
$8K Buy
300
+100
+50% +$2.24K ﹤0.01% 2374
2020
Q3
$4K Sell
200
-100
-33% -$1.77K ﹤0.01% 2412
2020
Q2
$5K Buy
+300
New +$4.57K ﹤0.01% 2258

Other funds holding CLLS

Steward Partners Investment Advisory's CLLS Position: Q4 2021 in Review

Steward Partners Investment Advisory sold out of Cellectis (CLLS) in Q4 2021, closing a stake of 100 shares — an estimated $1K sold.

Steward Partners Investment Advisory first reported a position in CLLS in Q2 2020 and held it in 6 quarters. The position peaked at $8K in Q4 2020. 57 funds tracked by Wall St. Rank hold CLLS as of Q4 2021.

  • Steward Partners Investment Advisory reported no remaining Cellectis position as of Q4 2021 after selling out during the quarter.
  • Steward Partners Investment Advisory sold 100 Cellectis shares in Q4 2021, an estimated $1K.
  • Steward Partners Investment Advisory first reported a position in Cellectis in Q2 2020 and held it in 6 quarters.
  • Steward Partners Investment Advisory's Cellectis position peaked at $8K in Q4 2020.
  • 57 funds tracked by Wall St. Rank held Cellectis as of Q4 2021.

Based on Steward Partners Investment Advisory's 13F filing for Q4 2021, filed 8 Feb 2022.